Prostate cancer is the second most common cancer in American men, behind skin cancer.1 And while most men diagnosed with it today do not die from it, the disease remains second only to lung cancer as the leading cause of cancer death in American men.1 For men diagnosed with prostate cance...
The following list of medications are related to or used in the treatment of this condition.Lupron Depot Casodex Zytiga bicalutamide XtandiView more treatment options What can I do to manage prostate cancer?Do not smoke. Nicotine can damage blood vessels and make it more difficult to manage ...
Prostate cancer: Commonly used medications cause clinically relevant decreases in serum PSA levelsComment on J Clin Oncol. 2010 Sep 1;28(25):3951-7.doi:10.1038/nrurol.2010.149WardeNickNat Rev UrolNature Reviews Urology
Men taking either of the two most common oral medications for advanced prostate cancer who had also undergone hormone therapy to treat their disease were at higher risk of serious metabolic or cardiovascular issues than patients who were only receiving hormone therapy, Michigan Medicine researchers have...
There are no warning signs of early prostate cancer. Learn more about the symptoms and signs of advanced prostate cancer and when you should call your doctor.
Drugs and Medications Repurposing Rucaparib As a Prostate Cancer Treatment Marianne Polvorosa - January 9, 2023 Diet Is there a prostate cancer prevention diet? Latest Health and Medical News Significant developments in a new urine test for prostate cancer Latest Health and Medical News A urine ...
The last decade has witnessed the debut of a completely new arsenal of therapies that target prostate cancer— specific pathways that improve overall survival. These new medications include cabazitaxel (Jevtana), abiraterone acetate (Zytiga), enzalutamide (Xtandi), sipuleucel-T (Provenge), and radium...
A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs.
In the field of advanced prostate cancer, a number of therapeutic agents are now available. The sequence of administration of medications with distinct mechanisms of action, toxicities and efficacies, will have a critical role in disease outcomes. The identification of biomarkers predicting response ...
INTRODUCTION: To assess the prevalence of prostate cancer (PCa) in men receiving immunosuppressive medications undergoing transrectal ultrasound guided (TRUS) prostate biopsy.METHODS: A total of 468 TRUS prostate biopsies from 368 men were studied. All men received one or more systemic immunosuppress...